Form 4: Teleflex Inc. Executive James Winters Reports Stock and Option Awards
SEC Form 4 Filing
James Winters, a Corporate VP at Teleflex Inc., reports the acquisition of stock and option awards on March 4, 2025.
Summary
- On March 4, 2025, James Winters, a Corporate VP at Teleflex Inc., reported transactions involving Teleflex Inc. securities.
- Winters acquired 1,896 shares of common stock at $0 and disposed of 5,307 shares.
- Following these transactions, Winters beneficially owns 5,307 shares of Teleflex Inc. common stock.
- Winters also acquired options to purchase 13,387 shares of common stock at an exercise price of $130.79, which vest in three equal installments on March 4, 2026, March 4, 2027, and March 4, 2028.
- The reported transactions include a restricted stock unit award granted under the Teleflex Incorporated 2023 Stock Incentive Plan, vesting 25% annually from March 4, 2026, to March 4, 2029.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects standard executive compensation practices. The disposal of some shares is slightly negative, but the acquisition of new shares and options balances this out.
Positives
- The granting of stock options and restricted stock units to a Corporate VP suggests an incentive to align with company performance and shareholder value.
Negatives
- The disposal of 5,307 shares by Winters could be interpreted negatively, although the acquisition of 1,896 shares and stock options partially offsets this concern.
Risks
- The vesting of the stock options and restricted stock units is contingent upon Winters' continuous service to the Issuer, creating a potential risk if he were to leave the company before full vesting.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules for the stock options and restricted stock units suggest a multi-year commitment from the executive.
Industry Context
Stock and option awards are a common practice in publicly traded companies to incentivize executives and align their interests with those of shareholders. The specific terms of these awards are typical for executive compensation packages.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Teleflex.
- Companies such as Medtronic, Boston Scientific, and Abbott Laboratories also utilize similar equity-based compensation plans to incentivize their executives.
- The vesting schedules and exercise prices are generally in line with industry norms for companies of similar size and market capitalization.
Stakeholder Impact
- The stock and option awards incentivize the executive to improve company performance, potentially benefiting shareholders.
- The awards also serve as a retention tool, encouraging the executive's continued service to the company, which can benefit employees and other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of transaction for common stock acquisition/disposal and option grant. |
| 03/04/2026 | First vesting date for both stock options and restricted stock units. |
| 03/04/2027 | Second vesting date for both stock options and restricted stock units. |
| 03/04/2028 | Third vesting date for stock options and restricted stock units. |
| 03/04/2029 | Final vesting date for restricted stock units. |
| 03/04/2035 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.